Table 3.

Multivariate analysis of the prognostic impact of clonal interference of signaling mutations on EFS and OS

Risk factorEFSOS
HR (95% CI)PHR (95% CI)P
Signaling clones     
 None   
 Single 1.38 (0.84-2.29) .21 1.01 (0.5-2.02) .98 
 Clonal interference 2.44 (1.44-4.14) .001 2.07 (1.03-4.15) .04 
Log(WBC) 1.26 (1.09-1.44) .001 1.11 (0.92-1.33) .27 
CBF type  .002  .008 
 inv(16)   
 t(8;21) 1.69 (1.2-2.37)  1.88 (1.18-2.98)  
Age, y 1.02 (1.01-1.03) .001 1.03 (1.02-1.04) <.0001 
Total VAF of signaling clones, % 0.5 (0.16-1.53) .22 0.58 (0.12-2.73) .49 
Risk factorEFSOS
HR (95% CI)PHR (95% CI)P
Signaling clones     
 None   
 Single 1.38 (0.84-2.29) .21 1.01 (0.5-2.02) .98 
 Clonal interference 2.44 (1.44-4.14) .001 2.07 (1.03-4.15) .04 
Log(WBC) 1.26 (1.09-1.44) .001 1.11 (0.92-1.33) .27 
CBF type  .002  .008 
 inv(16)   
 t(8;21) 1.69 (1.2-2.37)  1.88 (1.18-2.98)  
Age, y 1.02 (1.01-1.03) .001 1.03 (1.02-1.04) <.0001 
Total VAF of signaling clones, % 0.5 (0.16-1.53) .22 0.58 (0.12-2.73) .49 

All analyses are stratified on the HTS platform.

or Create an Account

Close Modal
Close Modal